NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

India-US Interim Trade Deal at Center of Controversy

Rahul Gandhi, leader of the opposition in the Lok Sabha, has continued to criticize Prime Minister Narendra Modi over the India-US Interim Trade Deal. In a post on X, Gandhi stated that it has been over 24 hours since he challenged the prime minister to scrap the deal, but Modi has yet to take action.

Gandhi's criticism comes after the US Supreme Court ruled that the tariffs imposed by Donald Trump on nations around the world were illegal. The ruling dealt a significant blow to Trump's economic agenda for his second term. Gandhi has alleged that Modi approved the agreement under external pressure linked to the threat of releasing "Epstein files" and an ongoing criminal case involving Gautam Adani in the US.

Gandhi has described the agreement as "an arrow in the heart of farmers" and has dared Modi to scrap it if he has the courage. However, Modi has yet to take action, with Gandhi suggesting that he has "quietly slipped off to Israel" to avoid addressing the issue.

Read also: Kumar Mangalam Birla to Address Concluding Function of RSS Training Camp

Key Figures:

  • Rahul Gandhi: Leader of the opposition in the Lok Sabha
  • Narendra Modi: Prime Minister of India
  • Donald Trump: Former President of the United States
  • Gautam Adani: Indian industrialist
  • US Supreme Court: Ruled that the tariffs imposed by Trump on nations around the world were illegal

Timeline:

  • US Supreme Court ruling: June 2023 (exact date not specified)
  • Rahul Gandhi's challenge: Over 24 hours prior to the date of the article (Wednesday)
  • Gautam Adani's ongoing criminal case: Ongoing, exact date not specified

Read also: The Cost of Healthcare: Why Predictability in Medical Inflation is Crucial for Health Insurance

Investor Takeaway

This news snippet does not have a direct impact on investor decisions.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.